C.R. Bard Inc (BCR)

BCR (NYSE:Health Services) EQUITY
$219.00
pos +0.00
+0.00%
Today's Range: 218.75 - 220.15 | BCR Avg Daily Volume: 470,200
Last Update: 05/27/16 - 4:02 PM EDT
Volume: 0
YTD Performance: 15.60%
Open: $0.00
Previous Close: $219.58
52 Week Range: $167.36 - $223.02
Oustanding Shares: 73,318,689
Market Cap: 16,099,317,731
6-Month Chart
TheStreet Ratings Grade for BCR
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 2 2 2
Moderate Buy 1 1 1 1
Hold 12 12 12 12
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.67 2.67 2.67 2.67
Latest Dividend: 0.24
Latest Dividend Yield: 0.43%
Dividend Ex-Date: 04/28/16
Price Earnings Ratio: 148.51
Price Earnings Comparisons:
BCR Sector Avg. S&P 500
148.51 154.40 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
11.91% 27.33% 108.29%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.80 0.10 0.05
Net Income -54.00 -0.70 -0.36
EPS -53.60 -0.70 -0.34
Earnings for BCR:
EBITDA 1.04B
Revenue 3.42B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $2.47 $2.62 $10.14 $11.25
Number of Analysts 12 11 13 14
High Estimate $2.49 $2.68 $10.19 $11.44
Low Estimate $2.45 $2.53 $10.10 $11.12
Prior Year $2.27 $2.28 $9.08 $10.14
Growth Rate (Year over Year) 8.66% 14.87% 11.70% 10.92%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Buyers should stay on the sidelines of Bard until a base is formed, potentially at a lower level.
Two significant, but subtle forces may threaten the group in the next 12 months.
We would begin trimming our position with a stop-loss just below $180.
With no top in sight, we remain bulls on this name.
Update
Aug 27, 2015 | 6:51 AM EDT
Coverage of BCR was started with a Sector Weight rating, Keybanc said. Stock is already pricing in a better sales outlook. 
The last two days have changed the entire structure of the markets.
There are some good buying ideas among these stocks.
Bullish
Apr 24, 2015 | 8:14 AM EDT
BCR was upgraded from Neutral to Buy, Bank of America/Merrill Lynch said. $200 price target. See higher growth from the drug eluting ba...
Traders should be looking for shorting opportunities.

Columnist Conversations

Nice finish today for CVX. The stock has been steadily improving after holding key support near the $98.0...
TMO agreed to purchase FEI Company for S4.2 billion dollars this morning. The company ran a call earlier this ...
I noted back at the <a href="https://www.thestreet.com/story/13558749/1/berkshire-hathaway-s-rally-is-showi...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.